We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab (STRATIFY-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01070836
Recruitment Status : Completed
First Posted : February 18, 2010
Last Update Posted : September 29, 2016
Information provided by (Responsible Party):

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2015
  Study Completion Date : November 2015